Freeflow Ventures

Freeflow Ventures is an early-stage venture capital firm dedicated to advancing science-driven solutions that address human and planetary health challenges. Founded in 2019 and headquartered in Pasadena, California, the firm focuses on investments that leverage deep technology and scientific innovation to create scalable, sustainable solutions. Their portfolio primarily includes companies emerging from leading scientific institutions such as the California Institute of Technology (Caltech) and the Jet Propulsion Laboratory (JPL), reflecting a strong commitment to supporting groundbreaking research and development.

The firm's investment strategy centers on early-stage companies operating in sectors like healthcare, life sciences, and environmental services. By targeting pre-seed to Series B funding stages, Freeflow Ventures aims to empower startups that are developing transformative technologies with the potential to make a significant impact on global health and the environment. Their approach combines financial support with strategic guidance, assisting portfolio companies in areas such as fundraising, marketing, hiring, and overall business strategy.

Since its inception, Freeflow Ventures has raised a total of $90 million across three funds, including a $35 million Fund Two and a $15 million Opportunity Fund, demonstrating substantial growth and investor confidence. The firm has made over 30 investments, with notable portfolio companies like Iambic Therapeutics, StrokeDx, Hydrosat, and Captura. These investments underscore Freeflow Ventures' dedication to fostering innovation that addresses critical challenges in human and planetary health, positioning them as a key player in the venture capital landscape focused on deep tech solutions.